Bosentan therapy for patients with severe Raynaud's phenomenon in systemic sclerosis

Ítems similars

• No effects of bosentan on microvasculature in patients with limited cutaneous systemic sclerosis
  per: Hettema, Martha E., et al.
  Publicat: (2009)
• Efficacy of bosentan in the treatment of Raynaud’s phenomenon in patients with systemic sclerosis never treated with prostanoids
  per: S. Parisi, et al.
  Publicat: (2014-03-01)
• Biosynthesis of thromboxane in patients with systemic sclerosis and Raynaud's phenomenon.
  per: Mikhailidis, D P, et al.
  Publicat: (1986)
• The patient experience of Raynaud’s phenomenon in systemic sclerosis
  per: Pauling, John D, et al.
  Publicat: (2019)
• Biosynthesis of thromboxane in patients with systemic sclerosis and Raynaud's phenomenon.
  per: Reilly, I A, et al.
  Publicat: (1986)